Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant KRT17 anticorps

Cet anticorps Lapin Monoclonal détecte spécifiquement KRT17 dans IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN7126634

Aperçu rapide pour Recombinant KRT17 anticorps (ABIN7126634)

Antigène

Voir toutes KRT17 Anticorps
KRT17 (Keratin 17 (KRT17))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 135
  • 52
  • 32
  • 19
  • 14
  • 12
  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 107
  • 39
  • 1
Lapin

Clonalité

  • 95
  • 51
  • 1
Monoclonal

Conjugué

  • 67
  • 15
  • 8
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp KRT17 est non-conjugé

Application

  • 108
  • 54
  • 36
  • 33
  • 27
  • 26
  • 25
  • 23
  • 16
  • 15
  • 15
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Specificité

    Cytokeratin 17 (CK17) is normally expressed in the basal cells ofcomplex epithelia but not in stratified orsimple epithelia. Antibody to CK17 is an excellent tool to distinguish myoepithelial cells from luminal epithelium of various glandssuch as mammary, sweat and salivary. CK17 is expressed in epithelial cells of various origins, such as bronchial epithelial cells and skin appendages. It may be considered as epithelial stem cell marker because CK17 Ab marks basal cell differentiation. CK17 is expressed in SCLC much higher than in LADC. Eighty-five percent of the triple negative breast carcinomas immunoreact with basal cytokeratins including anti-CK17. Also important is that cases of triple negative breast carcinoma with expression of CK17 show an aggressive clinical course. Additionally, anti-CK17 and anti-MUC1 immunoreactivity represents pancreatobiliary subtype whereas anti-MUC2 and anti-CDX-2 positivity defines intestinal subtype.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant full-length human KRT17 protein

    Isotype

    IgG
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: T24 cells. Humanskin, bladder or cervix.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    KRT17 (Keratin 17 (KRT17))

    Autre désignation

    KRT17

    Sujet

    K17, Keratin Type I Cytoskeletal 17, Keratin-17, KRT17, PCHC1,Cytokeratin 17 (CK17) (Basal Epithelial Marker)
    Cellular localisation: Cytoplasm.

    Poids moléculaire

    46kDa

    ID gène

    3872, 2785

    UniProt

    Q04695
Vous êtes ici:
Chat with us!